Ramsay Frances Dass
Internal Medicine · Oak Park, MINPI 1518900901
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 26.7% of the total. Reporting peaked in 2021 at $2,267 and has fallen 88.1% since, to $270 in 2024. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $33.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$899
- Boehringer Ingelheim$583
- CSL Behring$472
- Amgen$321
- plus $2K from 15 others
What the payments were for
- Food & beverage$7,594100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $2,026 |
| GSK | 57 | $1,735 |
| Regeneron Healthcare Solutions, Inc. | 31 | $899 |
| Boehringer Ingelheim | 16 | $583 |
| CSL Behring | 18 | $472 |
| Amgen | 3 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $290 |
| Lilly USA, LLC | 10 | $212 |
| Sanofi | 4 | $192 |
| Pfizer | 8 | $192 |
| Amarin Pharma, Inc. | 3 | $149 |
| Novo Nordisk | 2 | $146 |
| Medtronic | 1 | $98 |
| Teva Pharmaceuticals USA, Inc. | 6 | $82 |
| Alk-abello, Inc | 3 | $60 |
| Kaleo, Inc. | 2 | $39 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Phadia US Inc. | 1 | $19 |
| Novartis | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,594 in reported general payments places this provider in the 95th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl | 19 | $269 |
| Baclofen | 15 | $195 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Oak Park
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
- James BazziDearborn Heights$368K
- Mohamad HatahetWaterford$352K
- A FendrickAnn Arbor$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.